文献速递肾小球疾病

足细胞通过miR-378a-3p调控肾小球基底膜蛋白nephronectin参与肾小球疾病

Podocytes regulate the glomerular basement membrane protein nephronectin by means of miR-378a-3p in glomerular diseases.
PubMed 文献 · Kidney Int · 2017-05-03

本研究探讨miR-378a-3p是否通过靶向nephronectin(NPNT)和VEGF-A调控肾小球疾病。斑马鱼中miR-378a-3p模拟物注射或npnt敲低导致相同表型(水肿、蛋白尿、足细胞足突消失、基底膜内疏松层增宽),VEGF-A不能 rescue,而突变3'UTR的Npnt constructs可预防。小鼠过表达miR-378a-3p证实肾小球功能障碍。FSGS和膜性肾病患者活检中miR-378a-3p升高、NPNT降低。结论:miR-378a-3p抑制NPNT是活动性肾小球疾病蛋白尿的新机制。

要点

  • miR-378a-3p通过抑制NPNT导致蛋白尿和肾小球基底膜改变。
  • 斑马鱼和小鼠模型均证实miR-378a-3p过表达引起肾小球功能障碍。
  • FSGS和膜性肾病患者肾小球miR-378a-3p升高、NPNT降低。

核心结论

  • miR-378a-3p介导的NPNT抑制是活动性肾小球疾病蛋白尿发生的新机制。

研究设计与样本

  • 研究采用斑马鱼、小鼠模型及患者肾活检组织进行实验。

主要发现

  • 斑马鱼中miR-378a-3p模拟物注射或npnt敲低导致水肿、蛋白尿、足细胞足突消失及基底膜内疏松层增宽。
  • 斑马鱼vegf-A蛋白不能挽救该表型,而突变3'UTR的鼠Npnt constructs可预防miR-378a-3p模拟物注射引起的表型。
  • 小鼠过表达miR-378a-3p证实肾小球功能障碍。
  • FSGS和膜性肾病患者活检显示miR-378a-3p表达增加、肾小球NPNT水平降低。

关键数值与推荐

  • miR-378a-3p有两个预测靶点:NPNT和VEGF-A。

临床怎么用

  • miR-378a-3p和NPNT可能作为活动性肾小球疾病(如FSGS和膜性肾病)的诊断标志物或治疗靶点。

局限性

  • 研究未报告样本量、具体数值及统计细节。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

The pathophysiology of many proteinuric kidney diseases is poorly understood, and microRNAs (miRs) regulation of these diseases has been largely unexplored. Here, we tested whether miR-378a-3p is a novel regulator of glomerular diseases. MiR-378a-3p has two predicted targets relevant to glomerular function, the glomerular basement membrane matrix component, nephronectin (NPNT), and vascular endothelial growth factor VEGF-A. In zebrafish (Danio rerio), miR-378a-3p mimic injection or npnt knockdown by a morpholino oligomer caused an identical phenotype consisting of edema, proteinuria, podocyte effacement, and widening of the glomerular basement membrane in the lamina rara interna. Zebrafish vegf-A protein could not rescue this phenotype. However, mouse Npnt constructs containing a mutated 3'UTR region prevented the phenotype caused by miR-378a-3p mimic injection. Overexpression of miR-378a-3p in mice confirmed glomerular dysfunction in a mammalian model. Biopsies from patients with focal segmental glomerulosclerosis and membranous nephropathy had increased miR-378a-3p expression and reduced glomerular levels of NPNT. Thus, miR-378a-3p-mediated suppression of the glomerular matrix protein NPNT is a novel mechanism for proteinuria development in active glomerular diseases.

来源:Kidney Int,查看原文。版权归原作者所有。

引用

  1. Müller-Deile J, Dannenberg J, Schroder P, et al. Podocytes regulate the glomerular basement membrane protein nephronectin by means of miR-378a-3p in glomerular diseases. Kidney Int. 2017. PMID: 28476557. doi:10.1016/j.kint.2017.03.005

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。